Ibere Pharmaceuticals 2005 Market Street, Suite 2030 Philadelphia, PA 19103Administrative Services Agreement • March 3rd, 2021 • Ibere Pharmaceuticals • Blank checks • New York
Contract Type FiledMarch 3rd, 2021 Company Industry JurisdictionThis Administrative Services Agreement (this “Agreement”) by and between Ibere Pharmaceuticals (the “Company”) and PIPV Capital LLC (the “Sponsor”), dated as of the date hereof, will confirm our agreement that, commencing on the date of the Company’s final prospectus (the “Start Date”), pursuant to a Registration Statement on Form S-1 and prospectus filed with the U.S. Securities and Exchange Commission (the “Registration Statement”) and continuing until the earlier of the consummation by the Company of an initial business combination or the Company’s liquidation (in each case as described in the Registration Statement on Form S-1 (File No. [•]) filed with the Securities and Exchange Commission) (such earlier date hereinafter referred to as the “Termination Date”), the Sponsor shall make available, or cause to be made available, to the Company, at 2005 Market Street, Suite 2030 Philadelphia, PA 19103 (or any successor location or other existing office locations of the Sponsor or any of
Ibere Pharmaceuticals 2005 Market Street, Suite 2030 Philadelphia, PA 19103Administrative Services Agreement • February 9th, 2021 • Ibere Pharmaceuticals • Blank checks
Contract Type FiledFebruary 9th, 2021 Company IndustryThis Administrative Services Agreement (this “Agreement”) by and between Ibere Pharmaceuticals (the “Company”) and PIPV Capital LLC (the “Sponsor”), dated as of the date hereof, will confirm our agreement that, commencing on the date of the Company’s final prospectus (the “Start Date”), pursuant to a Registration Statement on Form S-1 and prospectus filed with the U.S. Securities and Exchange Commission (the “Registration Statement”) and continuing until the earlier of the consummation by the Company of an initial business combination or the Company’s liquidation (in each case as described in the Registration Statement on Form S-1 (File No. [•]) filed with the Securities and Exchange Commission) (such earlier date hereinafter referred to as the “Termination Date”), the Sponsor shall make available, or cause to be made available, to the Company, at 2005 Market Street, Suite 2030 Philadelphia, PA 19103 (or any successor location or other existing office locations of the Sponsor or any of